Kuria Therapeutics
Manufacturing · Arkansas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6834 Cantrell Rd, Little Rock, Arkansas,...Website
www.kuriatx.comRevenue
<$5 MillionIndustry
About Kuria Therapeutics
Kuria Therapeutics Org Chart
Is Kuria Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Kuria Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Kuria Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Kuria Therapeutics
Check if Kuria Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Kuria Therapeutics launches new products
Click to see if Kuria Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Kuria Therapeutics recently announced quarterly report
Kuria Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Kuria Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Kuria Therapeutics
Compare insights from companies similar to Kuria Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kuria Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kuria Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kuria Therapeutics.
Kuria Therapeutics Tech Stack
A closer look at the technologies used by Kuria Therapeutics
Kuria Therapeutics News & Media
SCOHIA PHARMA and Kuria Therapeutics Announce Issuance of Key Patent Covering Novel Nrf2 Activator
KANAGAWA, Japan & LITTLE ROCK, Ark.--(BUSINESS WIRE)--SCOHIA PHARMA, Inc, a Japanese biotech company dedicated to developing medicines for lifestyle-related diseases with high unmet needs, and Kuria Therapeutics, Inc., a U.S. pharmaceutical company developing novel therapeutics for ophthalmic and dermal diseases, today announced that the U.S. Patent Office has issued a composition-of-matter patent covering SCO-116, a novel Nrf2 activator being developed by Kuria for prevention and treatment of
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kuria Therapeutics
Based out of Little Rock, Kuria Therapeutics, is a pharmaceutical company with a focus on ophthalmic and dermal therapeutics.... Read More